Saturday 17 October 2026 Export CLGN’s income statement to Excel — free account

CollPlant Biotechnologies Ltd. Sponsored ADR

CollPlant Biotechnologies Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $2.4 million, up 360.4% from fiscal 2024. In the quarter to June 2026, revenue fell 39.7%, EPS grew 32.5% and free cash flow grew 5.08%, each against the same quarter a year earlier.

3.60 0.08 −2.17%

Follow CLGN

Alert me

Market cap: $7.0M
P/E: 0.0×
Fwd P/E: −0.7×
Dividend yield: —
F-score: 4/9
Altman Z: −16.87
Beneish M: −3.20
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	15.84	18.94	7.21	13.83
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(2.16)	(2.42)	(5.82)	(11.90)
P/B ratio Full definition →	1.71	1.51	2.81	3.68
Price to Tangible BV Full definition →	1.74	1.53	2.84	3.71
EV/Sales Full definition →	23.71	21.07	7.00	12.46
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(0.67)	(0.73)	(1.76)	(3.10)
EV/FCF Full definition →	(0.67)	(0.72)	(1.75)	(3.07)
Quick Ratio Full definition →	1.35	1.99	2.31	3.45
Current Ratio Full definition →	1.57	2.27	2.53	3.66
Net Debt/EBITDA Full definition →	1.21	1.59	2.03	2.69
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.03	0.03	0.16	0.14
Operating CF/Net income Full definition →	0.86	0.98	0.92	0.83
Capex/Depreciation Full definition →	0.07	(0.03)	(0.07)	0.00
Interest Coverage Full definition →	(28.31)	—	—	—
Research and Development Expense of Revenue Full definition →	1,078.70%	2,298.63%	3,300.00%	2,712.99%
Selling, General and Administrative Expense of Revenue Full definition →	937.04%	1,635.62%	1,730.00%	1,592.21%
Intangible Assets out of Total Assets Full definition →	0.01	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →	152.78%	246.58%	(30.00%)	366.23%
Graham Net Nets Full definition →	(0.07)	0.17	0.12	0.14
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(271.40%)	(193.71%)	(67.02%)	(37.92%)
Free Cash Flow Yield Full definition →	(223.27%)	(154.28%)	(55.54%)	(29.40%)
Revenue per Share Full definition →	0.07	0.05	0.05	0.06
Operating CF per Share Full definition →	(1.62)	(2.22)	(2.41)	(2.26)
Capex per Share Full definition →	0.01	0.00	(0.01)	0.00
Free Cash Flow per Share Full definition →	(1.61)	(2.22)	(2.42)	(2.26)
Cash per Share Full definition →	2.05	3.37	4.88	6.94
Shareholders Equity per Share Full definition →	2.04	3.55	4.98	7.31
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.04	3.55	4.98	7.31
Free Cash Flow Full definition →	(2.32)	(3.05)	(2.95)	(2.88)
Working Capital Full definition →	1.41	3.10	4.08	6.99
Capital Expenditures Full definition →	0.01	(0.01)	(0.01)	0.00
Net Current Asset Value Full definition →	(0.36)	1.24	2.04	4.84
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	(0.13)	0.08	0.25	0.01
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	0.38	0.34	0.40	0.34
Average Payables Full definition →	0.41	0.70	0.74	0.81
Average Inventory Full definition →	0.55	0.68	0.51	0.50
Average Assets Full definition →	12.32	13.20	14.75	18.27
Average Common Equity Full definition →	7.73	8.64	9.77	13.11

Fold the line items

Columns are period end dates · fundamentals updated 6 Oct 2026

Stockrow Weekly